What a Visual Aid Has to Carry Before It Can Be Creative

3 min read

A visual aid comes back from review. The design passed. What held the page back was a claim on page three with no reference beneath it, and the word 'safe' used without a qualifier. Weeks of creative work waited on a couple of elements nobody thought to check, because next to the creative they felt clerical.

A visual aid, and the leave behind literature that travels with it, is a promotional material first and a piece of design second. Before it can be persuasive, it has to carry what a promotional material is expected to carry. UCPMP sets much of this out in its provisions on textual and audio-visual promotion, and reviewers read a page against the same expectations. These are the compliance elements that sit around the creative, and they are the quiet reason collaterals bounce.

What a Page Has to Carry

Several of these expectations are specific enough to check on sight. The generic name, the active ingredients, shown alongside the brand name rather than hidden away from it. The manufacturer's details present. The indication kept inside the terms of the drug's marketing approval and no wider. Every claim of efficacy carrying a reference that actually supports it, reflecting current evidence. The word 'safe' never used without qualification, since an unqualified 'safe' implies an absolute the data cannot hold. The word 'new' kept off any drug that has been available or promoted in India for more than a year. No photograph or name of a doctor used to lend the page authority. Nothing on the page that disguises the fact that it is promotion. Where the material is audio-visual, printed material behind it that shows it complies.

Why These Get Missed

In the cycle, attention goes to the headline, the visual, the data story, the things that will move a prescription. The required elements feel like paperwork, so they get added at the end, by which point the layout is locked and there is no clean place for them. A reference squeezed into a margin at the last minute is the tell of a page that treated compliance as an afterthought.

The Cost of a Missing Element

The cost is more than a review round. A missing element found after distribution is a reprint, and a reprint of a visual aid across a field force is not a small number. The element that felt clerical becomes the most expensive thing on the page.

Designing the Frame First

The brand teams that move fastest through review tend to do one thing differently. They place the required elements first, on a blank layout, before the creative begins. Generic name, manufacturer details, the approved indication, the references, the qualified language, all positioned as part of the design rather than dropped on top of it. The creative is then built into the space that remains, which is usually more than enough. A page built this way rarely comes back for a missing element, because there was never a moment when the element was missing.

Craft still matters. A dull but compliant visual aid loses the doctor in the ninety seconds it gets, and losing the doctor is its own kind of failure. The creative is what persuades the doctor. The required elements are what let the page reach the doctor at all, and they are cheapest to get right at the start, on an empty layout, before anything has been built on top of them.

Disclaimer: This is a practitioner view for brand teams. The exact requirements depend on the material and the product, and the final call sits with your medical and regulatory team.

Pranav Mehta
Written byPranav MehtaFounder, MarketingSense

Pranav Mehta is the Founder of ImpactPlus Ventures, the company behind MarketingSense. With over 25 years of experience across pharmaceutical marketing, brand strategy, and commercial operations, he works with pharma brand teams to rethink how promotional collaterals are built, reviewed, and improved before they reach the field.